Endothelial cell-targeting, ROS-ultrasensitive drug/siRNA co-delivery nanocomplexes mitigate early-stage neutrophil recruitment for the anti-inflammatory treatment of myocardial ischemia reperfusion injury. (15th April 2022)

• Record Type: Journal Article
• Authors: Hou, Mengying; Wu, Xuejie; Zhao, Ziyin; Deng, Qiurong; Chen, Yongbing; Yin, Lichen
• Is Part Of: Acta biomaterialia. Volume 143(2022)
• Page Start: 344
• Page End: 355
• Publication Date: 2022-04-15
• Subjects: Myocardial ischemia reperfusion injury (MIRI) -- Drug/siRNA co-delivery -- Ditellurium-crosslinked polyethylenimine -- ROS responsiveness -- Anti-inflammation -- Neutrophil recruitment; MIRI myocardial ischemia reperfusion injury -- ROS reactive oxygen species -- DXM dexamethasone -- siVCAM-1 siRNA for vascular cell adhesion molecule-1 -- RPPT cRGD-PEG-modified, ditellurium-crosslinked PEI -- PD@RPPT/sV NCs co-loaded with DXM and siVCAM-1 -- PD@RPPT/sN NCs co-loaded with DXM and siNC -- PN@RPPT/sV siVCAM-1-loaded NCs; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2022.02.018
• Languages: English
• ISSNs: 1742-7061

Abstract

Abstract: Neutrophils serve as a key contributor to the pathophysiology of myocardial ischemia reperfusion injury (MIRI), because the unregulated activation and infiltration of neutrophils lead to overwhelming inflammation in the myocardium to cause tissue damage. Herein, endothelial cell-targeting and reactive oxygen species (ROS)-ultrasensitive nanocomplexes (NCs) were developed to mediate efficient co-delivery of VCAM-1 siRNA (siVCAM-1) and dexamethasone (DXM), which cooperatively inhibited neutrophil recruitment by impeding neutrophil migration and adhesion. RPPT was first synthesized via crosslinking of PEI 600 with ditellurium followed by modification with PEG and the endothelial cell-targeting peptide cRGD. RPPT was allowed to envelope the DXM-loaded PLGA nanoparticles and condense the siVCAM-1. After systemic administration in rats experiencing MIRI, the cRGD-modified NCs efficiently targeted and entered the inflamed endothelial cells, wherein RPPT was sensitively degraded by over-produced ROS to trigger intracellular siVCAM-1 release and potentiate the VCAM-1 silencing efficiency. As a consequence of the complementary function of DXM and siVCAM-1, the NCs notably mitigated neutrophil infiltration into ischemic myocardium, provoking potent anti-inflammatory efficacy to reduce MIRI and recover cardiac function. The present study offers an effective approach for the controlled co-delivery of siRNA and drug cargoes, and it also highlights the importance of multi-dimensional manipulation of neutrophils in anti-inflammatory treatment. Statement of significance: The unregulated activation and infiltration of neutrophils lead to overwhelming inflammation in the myocardium after myocardial ischemia reperfusion injury (MIRI). Here, endothelial cell-targeting and ROS-ultrasensitive nanocomplexes (NCs), comprised of PLGA NPs decorated with cRGD-poly(ethylene glycol) (PEG)-modified, ditellurium-crosslinked PEI (RPPT), were developed to mediate efficient co-delivery of VCAM-1 siRNA (siVCAM-1) and dexamethasone (DXM). DXM and siVCAM-1 with complementary functions inhibited both the migration and adhesion of neutrophils, efficiently interventing the neutrophil recruitment and interrupting the self-amplified inflammation cascade in the injured myocardium. The molecular design of RPPT renders an effective example for constructing polymeric materials with high ROS sensitivity, and it resolves the critical dilemma related to polycation-mediated siRNA delivery, such as siRNA encapsulation versus release, and transfection efficiency versus toxicity. Graphical abstract: Image, graphical abstract